In the notice published in the New Zealand Gazette, 26 January 2017, Issue No. 8, Notice No. 2017-go297, replace the Schedule with:
Schedule
Product: |
Proleukin |
Note: This renewed consent is valid for two years from 29 January 2017.
Product: |
Verorab |
Note: This renewed consent is valid for six months from 27 January 2017.
Dated this 12th day of April 2017.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).